Product NDC: | 16477-185 |
Proprietary Name: | Donatussin |
Non Proprietary Name: | Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride |
Active Ingredient(s): | 12.5; 120; 5 mg/5mL; mg/5mL; mg/5mL & nbsp; Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16477-185 |
Labeler Name: | Laser Pharmaceuticals, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110928 |
Package NDC: | 16477-185-15 |
Package Description: | 15 mL in 1 BOTTLE (16477-185-15) |
NDC Code | 16477-185-15 |
Proprietary Name | Donatussin |
Package Description | 15 mL in 1 BOTTLE (16477-185-15) |
Product NDC | 16477-185 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Chlophedianol Hydrochloride, Guaifenesin, Phenylephrine Hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20110928 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Laser Pharmaceuticals, LLC |
Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 12.5; 120; 5 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes |